Silence Therapeutics plc (SLN)

Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	82.03	121.33	68.79	66.05	99.57	37.48
Short-Term Investments	20.16	26	-	19.67	-	13.65
Cash & Short-Term Investments	102.19	147.33	68.79	85.72	99.57	51.13
Cash Growth	-40.89%	114.18%	-19.75%	-13.91%	94.75%	15.18%
Accounts Receivable	0.03	0.97	0.29	1.1	0.45	40.01
Other Receivables	22.15	25.94	23.69	19.79	11.04	5.75
Receivables	22.18	26.91	23.98	20.9	11.49	45.76
Prepaid Expenses	-	13.12	10.39	9.88	5.83	5.38
Other Current Assets	9.26	-	-	-	-	2.04
Total Current Assets	133.63	187.37	103.15	116.5	116.9	104.31
Property, Plant & Equipment	1.85	1.98	2.31	2.65	2.63	1.54
Long-Term Investments	-	-	-	0.34	0.41	0.41
Goodwill	10.61	9.39	9.98	9.65	10.28	11.09
Other Intangible Assets	0.3	0.31	0.36	0.39	0.03	0.02
Other Long-Term Assets	0.4	3.59	3.65	-	-	-
Total Assets	146.79	202.64	119.45	129.53	130.25	117.38
Accounts Payable	16.99	3.7	3.35	3.84	5.5	3.12
Accrued Expenses	-	12.05	11.72	10.67	8.85	8.06
Current Portion of Leases	0.09	0.12	0.23	0.54	0.19	0.47
Current Income Taxes Payable	-	0.65	0.47	0.71	0.25	-
Current Unearned Revenue	0.3	0.31	6.57	10.68	5.75	23.27
Total Current Liabilities	17.38	16.82	22.34	26.44	20.54	34.92
Long-Term Leases	0.1	-	0.12	-	-	-
Long-Term Unearned Revenue	55.25	51.79	75	76.49	98.17	70.09
Total Liabilities	72.73	68.61	97.46	102.93	118.71	105.01
Common Stock	10.29	10.29	8.85	6.49	6.08	5.69
Additional Paid-In Capital	617.65	609.56	455.77	273.11	249.6	209.89
Retained Earnings	-550.8	-485.83	-442.62	-317.2	-301.91	-251.51
Comprehensive Income & Other	-3.07	-	-	64.19	57.78	48.3
Shareholders' Equity	74.06	134.02	21.99	26.59	11.54	12.37
Total Liabilities & Equity	146.79	202.64	119.45	129.53	130.25	117.38
Total Debt	0.18	0.12	0.35	0.54	0.19	0.47
Net Cash (Debt)	102.01	147.22	68.44	85.18	99.39	50.66
Net Cash Growth	-40.93%	115.09%	-19.65%	-14.29%	96.17%	15.12%
Net Cash Per Share	2.15	3.18	1.85	2.65	3.35	1.86
Filing Date Shares Outstanding	47.23	47.22	46.5	35.95	29.93	27.77
Total Common Shares Outstanding	47.23	47.22	39.62	35.94	29.93	27.77
Working Capital	116.25	170.54	80.82	90.06	96.36	69.39
Book Value Per Share	1.57	2.84	0.56	0.74	0.39	0.45
Tangible Book Value	63.15	124.32	11.65	16.56	1.23	1.25
Tangible Book Value Per Share	1.34	2.63	0.29	0.46	0.04	0.05
Machinery	-	6.34	6.44	6.01	6.92	5.55

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q